Back to Journals » Journal of Asthma and Allergy » Volume 17

Review

Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types

       
Total article views   HTML views PDF downloads Totals
2,335 Dovepress* 2,268+ 76 2,344
PubMed Central* 67 44 111
Totals 2,335 120 2,455
*Since 19 March 2024

View citations on PubMed Central and Google Scholar